Epidemiology of diabetes mellitus and microvascular complications
https://doi.org/10.14341/2072-0351-6216
Abstract
The present work is devoted studying of epidemiological situation of diabetes mellitus (DM). The data on prevalence and incidence of DM and itsmicrovascular complications among adult population in the different countries of the world is presented. The analysis of numerous researches allowsto speak about high prevalence of this disease all over the world and to allocate a number of the most significant risk factors of development andprogressing of diabetic complications.
About the Authors
Oksana Vladimirovna Maslova
Endocrinology Research Centre, Moscow
Yury Ivanovich Suntsov
Endocrinology Research Centre, Moscow
References
1. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the preva - lence of diabetes for 2010 and 2030 // Diabetes Res. Clin. Pract. - 2010. - Vol. 87. - № 1. - P. 4-14.
2. International Diabetes Federation. Triennial Report (1991-1994) and Directory // International Diabetes Federation, Brussels. - 1994.
3. International Diabetes Federation // Diabetes Atlas Second Edition. - 2003. - P. 17-71.
4. Gregg E.W., Cadwell B.L., Cheng Y.J. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. // Diabetes Care. - 2004. - Vol. 27. - № 12. - P. 2806-2812.
5. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2003 // Reved. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Preven - tion. - 2004.
6. Thefeld W. Prevalence of diabetes mellitus in the adult German pop - ulation // Gesundheitswesen. - 1999. - Vol. 61. - Spec: S.85-89.
7. Sekikawa A., Eguchi H., Tominaga M., Igarashi K., Ade T., Manaka H., Sasaki H., Fukuyama H., Kato T., Kiyohara Y., Fu - jishima M. Prevalence of type 2 diabetes mellitus and impaired glucose tollerantce in a rural area of Japan. The Funagata diabetes study // Diabetes Complications. - 2000. - Vol. 14. - P. 78-83.
8. Dunstan D.W., Zimmet P.Z., Welborn T.A., De Courten M.P., Cameron A.J., Sicree R.A., Dwyer T., Colagiuri S., Jolley D., Knuiman M., Atkins R., Shaw J.E. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study // Diabetes Care. - 2002. - Vol. 25. - P. 829-834.
9. Ministry of Health NZ. Diabetes in New Zealand: Models and forecasts 1996-2011 // New Zealand, Wellington. - 2002.
10. Tamayo-Marco B., Faure-Nogueras E., Roche-Asensio M.J. Prevalence of diabetes and impaired glucose tolerance in Aragon, Spain // Diabetes Care. - 1997. - Vol. 20 - P. 534-536.
11. Sayeed M.A., Mantab H., Khanam P.A., Latif Z.A. Diabetes and impaired fasting glycamia in a rural population of Bangladesh // Diabetes Care. - 2003. - Vol. 26. - № 4 - P. 1034-1039.
12. The DECODE Study Group. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 13 European cohorts // Diabetes Care. - 2003. - Vol. 26. - № 1. - P. 61-69.
13. Malik M., Bakir A., Abi Saab B., Roglic G., King H. Prevalence of Diabetes Impaired Fasting Glucose, Impaired Glucose Tolerance, Hupertension and Obesity in the Multi-ethnic population of the United Arab Emirates. Abu Dhabi. - 2002.
14. Soderberg S., Zimmet P., Tuomilehto J. Increasing prevalence of Type 2 diabetes mellitus in ethnic groups in Mauritius // Diabet Med. - 2005. - Vol. 22. - P. 61-68.
15. Karvonen M., Viik-Kajander M., Moltchanova E., Libman I., LaPorte R., Tuomilehto J. Incidence of childhood Type 1 diabetes Worldwide // Diabetes Care. - 2000. - Vol. 23. - № 10. - P. 1516-1526.
16. Cardwell C.R., Carson D.J., Patterson C.C. Higher incidence of childhood- onset type 1 diabetes mellitus in remote areas: a UK regional smallarea analysis // Diabetologia. - 2006. - Vol. 49. - P. 2074-2077.
17. Donnelly R., Emslie-Smith A.M., Gardner I.D., Morris A.D. Vascular complications of diabetes // BMJ. - 2000. - Vol. 15. - № 320(7241). - P. 1062-1066.
18. Klein R., Klein BEK., Moss S.E., Davis M.D., DeMets D.L. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years // Arch. Ophthalmol. - 1984. - № 102. - P. 520-526.
19. McLeod B.K., Thompson J.R., Rosenthal A.R. The prevalence of retinopathy in the insulin-requiring diabetic patients of an English country town // Eye. - 1988. - № 2. - P. 424-430.
20. Jerneld B. Prevalence of diabetic retinopathy // Acta Scand. Ophthalmol. - 1988. - Vol. 188. (Suppl.). - P. 3-32.
21. Constable I.J., Knuiman M.W., Welborn T.A., Cooper R.L., Stanton K.M., McCann V.J., Grose G.C. Аssessing the risk of diabetic retinopathy // Am. J. Ophthalmol. - 1984. - № 97. - P. 53-61.
22. Danielsen R., Jonasson F., Helgason T. Prevalence of retinopathy and proteinuria in Type I diabetics in Iceland // Acta Mad. Scand. - 1982. - № 212. - P. 277-280.
23. The EURODIAB IDDM Complications Study. Microvascular and acute complications in IDDM patient // Diabetologia. - 1994. - Vol. 37. - № 3. - P. 278-285.
24. King H., Balkau B., Zimmet P., Taylor R. Diabetic retinopathy in Nauruans // Am. J. Epidemiol. - 1983. - № 117. - P. 659-667.
25. Nielsen N.V. Diabetic retinopathy. II. The course of retinopathy in diabetics treated with oral hypoglycemic agents and diet regime alone. A one-year epidemiologic cohort study of diabetes mellitus. The Island of Falster, Dermark // Acta Ophthalmol. - 1984. - № 62. - P. 266-273.
26. Ross S.A., Huchcroft S.A. Hyperlipidemia and vascular risk factors among diabetics in southern Alberta // Clin. Invest. Med. - 1989. - № 12. - B25.
27. Waked N., Nacouzi R., Haddad N., Zaini R. Epidemiology of diabetic retinopathy in Lebanon. // Acta Ophtalmol. - 2006. - Vol. 29. - № 3. - P. 289-295.
28. Wilczynski M., Dziegielewski K. Evaluation of state of the organ of sight in patients with diabetes type II // Klin Oczna. - 2005. - Vol. 107. - № 10-12. - P. 672-674.
29. Lee E.T., Russell D.J., Warn A., Klein R., Tolbert B. Prevalence of eye diseases and its relationship with diabetes in an American Indian Population - The Vision Keepers Study // Diabetes research clinical practice. - 2000. - Vol. 50 (Suppl.). - S. 248 - P.1035.
30. Lee E.T., Lee V.S., Kingsley R.M., Lu M., Russell D., Assal N.R., Wilkinson C.P., Bradford R.H. Diabetic retinopathy in Oklahoma Indians with NIDDM: Incidence and risk factors // Diabetes Care. - 1992. - № 15. - P. 1620-1627.
31. Brechner R.J., Cowie C.C., Howie L.J., Herman W.H. Will J.C., Harris M.I. Ophthalmic examination among adults with diagnosed diabetes mellitus // JAMA. - 1993. - № 270. - P. 1714-1718.
32. Stolarza Z.S., Valli H.V., Szuster J.S., Lerner M.L., Marcello S.M., Del Hoyo N.D.H., Gonzalez C.G., Benavides B.B., Dibenedetto A.D., Gossn E.G., Pagnotta L.P. Preliminary study on th frequency and degree of diabetic retinopathy among a hospital population // Diabetes research clinical practice. - 2000. - Vol. 50 (Suppl.). - S. 251 - P.1044.
33. Parving H-H., Hommel E., Mathiesen E., Skott P., Edsberg B., Bahnsen M., Lauritzen M., Hougaard P. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes // British Medical Journal. - 1988. - Vol. 296. - P. 156-160.
34. Parving H-H., Lewis JB., Ravid M., Remuzzi G., Hunsicker L.G., DEMAND investigators - Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global prespective // Kidney Int. - 2006. - Vol. 69. - № 11. - P. 2057-2063.
35. Cueto-Manzano A.M., Cortes-Sanabria L., Martinez-Ramirez H.R., Rojas-Campos E., Barragan G., Alfaro G., Flores J., Anaya M., Canales-Munoz J.L. Detection of early nephropathy in Mexican patients with type 2 diabetes mellitus // Kidney Int Suppl. - 2005. - № 97. - S. 40-45.
36. Manaviat M.R., Shoja M. Retinopathy and microalbuminuria in type II diabetic patients // BMC Ophthalmol. - 2004. - Vol. 4. - P. 9.
37. Yeung V.T., Lee K.F., Chan S.H., Ho L.F., Leung S.K., Wong H.Y. Micro- Albuminuria Prevalence Study (MAPS) in hypertensive type 2 diabetic patients in Hong Kong // Hong Kong Med J. - 2006. - Vol. 12. - № 3. - P. 185-190.
38. Cederholm J., Eliasson B., Nilsson P.M., Weiss L., Gudbjornsdottir S., for the steering committee of the Swedish National Diabetes Register. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients // Diabetes Research and Clinical Practice. - 2005. - Vol. 67. - P. 258-266.
39. Centers for Disease Control and Prevention (CDC) - Incidence of end-stage renal disease among persons with diabetes - United States, 1990-2002 // MMWR Morb. Wkly Rep. - 2005. - Vol. 54. - № 43. - P. 1097-1100.
40. United States Renal Data System USRDS annual data report 2004. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD - 2004.
41. Patient Registration Committee, Japanese Society for Dialysis Therapy - An overview of regular dialysis treatment in Japan as of 31 December 2003 // Ther Apher Dial. - 2005. - Vol. 9. - № 6. - P. 431-458.
42. Martinez-Castelao A., De Alvaro F., Gorriz J.Z. Epidemiology of diabetic nephropathy in Spain // Kidney Int Suppl. - 2005. - № 99. - S. 20-24.
43. Cusumano A.M., Di Gioia C., Hermida O., Lavorato C. The Latin American Dialysis and Renal Transplantation Registry Annual Report 2002 // Kidney Int Suppl. - 2005. - № 97. - S. 46-52.
44. Hovind P., Tarnow L., Rossing P. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study // BMJ. - 2004. - Vol. 328. - P. 1105.
45. Vergouwe Y., Soedamah-Muthu S., Zgibor J., Chaturvedi N., Forsblom C., Snell-Bergeon J.K., Maahs D.M., Groop P-H., Rewers M., Orchard T.J., Fuller J.H., Moons G.M. Progression to microalbuminuria in type 1 diabetes: development and validation of prediction rule // Diabetologia. - 2010. - Vol. 53. - P. 254-262.
46. American Diabetes Association. Standards of medical care in diabetes // Diabetes Care. - 2007. - Vol. 30. - S. 4-41.
47. Sabanayagam C., Liew G., Tai ES., Shankar A., Lim S.C., Subramaniam T., Wong T.Y. Relationship between glycated haemoglobin and microvascular complications: Is there a natural cut-off point for the diagnosis of diabetes? // Diabetologia. - 2009. - Vol. 52. - P. 1279-1289.
48. Kibriya M.G., Mahtab H. Micro-vascular complications in type 2 diabetes in Bangladesh: The Diabcare-Asia, Bangladesh Project // Diabetes research clinical practice. - 2000. - Vol. 50 (Suppl.) - S. 257 - P. 1068.
49. Tapp R.J., Zimmet PZ., Harper CA., de Courten M.P., McCarty D.J., Balkau B., Taylor H.R., Welborn T.A. Shaw J.E. Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia // Diabetes Res. Clin. Pract. - 2006. - Vol. 73. - P. 315-321.
50. Harris M.I., Klein R., Cowie C.C., Rowland M., Byrd-Holt D.D. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican- Americans than in non-Hispanic whites with type 2 diabetes? // Diabetes Care. - 1998. - Vol. 21. - № 8. - P. 1230-1235.
51. Scheffel R.S., Bortolanza D., Weber C.S. Prevalence of micro and macroangiopatic chronic complications and their risk factors in the care of out patients with type 2 diabetes mellitus. // Assoc Med Bras. - 2004. - Vol. 50. - № 3. - P. 263-267.
52. Choi H.S., Sung K.C., Lee K.B. The prevalence and risk factors of microalbuminuria in normoglycemic, normotensive adults // Clin Nephrol. - 2006. - Vol. 65. - № 4. - P. 256-261.
53. Col M., Ocaktan E., Ozdemir O., Yalcin A., Tuncbilek A. Microalbuminuria: prevalence in hypertensives and diabetics // Acta. Med. Austriaca. - 2004. - Vol. 31. - № 1. - P. 23-29.
54. DCCT Research Group, Bethesda, MA, USA. Effect of Intensive Therapy on the development and progression of diabetic nefropathy in the Diabetes Control and Complications // Trial. Kidney Int. - 1995. - № 47. - P. 1703-1720.
55. Genuth S. Insights from the diabetes control and complications trial/ epidemiology of diabetes interventions and complications study on the of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes // Endocr. Pract. - 2006. - № 12. - Suppl 1. - S34- 41.
56. Stratton I.M., Adler A.I., Neil HAW., Matthews D.R., Manley S.E., Cull C.A., Hadden D., Turner R.C., Holman R.R. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study // BMJ. - 2000. - Vol. 12. - № 321 (7258). - P. 405-412.
57. Adler A.I., Stratton I.M., Neil HAW., Yudrin J.S., Matthews DR., Cull C.A., Wright AD., Turner R.C., Holman R.R. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study // BMJ. - 2000. - Vol. 12. - № 321 (7258). - P. 412-419.
58. ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial) // Lancet. - 2007. - Vol.10. - S140-167.
59. Dluhy R.G., McMahon G.T. Intensive glycemic control in the ACCORD and ADVANCE trials // N. Engl. J. Med. - 2008. - № 358. - P. 2630- 2633.
60. Patel A., MacMahon S., Chalmers J. et al. ADVANCE Collaborative Group. Intensive blood glucose and vascular outcomes in patients with type 2 diabetes // N. Engl. J. Med. - 2008. - № 358. - P. 2560-2572.
61. Murase Y., Imagawa A., Hanafusa T., et al. Fulminant type 1 diabetes as a high risk group for diabetic microangiopathy - a nationwide 5-yearstudy in Jaspan // Diabetologia. - 2007. - Vol. 50. - P. 531-537.
62. Fong D.S., Aiollo L., Gardner T.W., King G.L., Blankenship G., Cavallerano J.D., Ferris F.L., Klein R. Retinopathy in Diabetes // Diabetes Care. - 2004. - Vol. 27. - S 84-87.
63. Mwendwa F.M., Otieno C.F., Kayima J.K., Amayo E.O., Otieno P.O. Risk factor profile and the occurrence of microvascular complications in short-term type 2 diabetes mellitus at Kenyatta National Hospital, Nairobi // East. Afr. Med. J. - 2005. - Vol. 82. - Suppl. 12. - S. 163-172.
64. Tapp R.J., Shaw J.E., Harper C.A., De Courten M.P., Balkau B., McCarty D.J., Taylor H.R., Welborn T.A., Zimmet P.Z. The prevalence of and factors associated with diabetic retinopathy in the Australian population // Diabetes Care. - 2003. - Vol. 26. - P. 1731-1737.
65. Rema M., Shanthirani C.S., Deepa R., Mohan V. Prevalence of retinopathy in a selected South Indian Population in the Chennai Urban Population Study (CUPS) // Diabetes research clinical practice. - 2000. - Vol. 50 (Suppl.). - S. 252. - P. 1049.
66. Wilczynski M., Dziegielewski K. Evaluation of state of the organ of sight in patients with diabetes type II // Klin Oczna. - 2005. - Vol. 107. - № 10-12. - P. 672-674.
67. Harris M.I., Klein R., Cowie C.C., Rowland M., Byrd-Holt D.D. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican- Americans than in non-Hispanic whites with type 2 diabetes? // Diabetes Care. - 1998. - V. 21. - № 8. - P. 1230-1235.
68. Leelawattana R., Pratipanawatr T., Bunnag P. Thailand diabetes registry project: prevalence of vascular complications in long-standing type 2 diabetes // J. Med. Assoc. Thai. - 2006. - Vol. 89. - Suppl. 1. - S 54-59.
69. Gudbjornsdottir S., Cederholm J., Nilsson P.M., Svensson A-M., Eliasson B. Result Report NDR 2005 // Socialstyrelsen, Stockholm. - 2006.
70. Lim H.S., Chew W.L.S., Emmanuel S., Goh L.G., Lau H.C., Lee C.H., Soon P.C., Tambyah J., Tan Y.Y., Thai A.C., Jorgensen L.N., Yeo J.P. Metabolic indices and complications in relation to duration of diabetes - Findings of the Diabcare-Asia (Singapore) Study // Diabetes research clinical practice. - 2000. - V. 50 (Suppl. 1). - S. 134 - P. 548.
71. Kibriya M.G., Mahtab H. Micro-vascular complications in type 2 diabetes in Bangladesh: The Diabcare-Asia, Bangladesh Project // Diabetes research clinical practice. - 2000. - Vol. 50 (Suppl.). - S. 257. - P. 1068.
72. Haffner S.M., Fong D. Podgor M.J., Ferris F.L., Wilson PWF - Diabetic retinopathy and cardiovascular disease in type II diabetics: the Framingham Heart Study and the Framingham Eye Study // Am. J. Epidemiol. - 1988. - V. 128. - P. 402-409.
73. Hamman R.F., Mayer E.J., Moo-Young G.A., Hildebrandt W., Marshall J.A., Baxter J. - Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM: San Luis Valley Diabetes Study // Diabetes. - 1989. - V. 38. - P. 1231-1237.
74. Tudor S.M., Hamman R.F., Baron A., Johnson D.W., Shetterly S.M. - Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes: San Luis Diabetes Study, Colorado // Diabetes Care. - 1998. - Vol. 21. - P. 53-61.
75. Harris E.L., Feldman S., Robinson C.R., Sherman S., Georgopoulos A. - Racial differences in the relationship between blood pressure and risk of retinopathy among individuals with NIDDM // Diabetes Care. - 1993. - V. 16. - P. 748-754.
76. Harris M.I., Klein R., Cowie C.C., Rowland M., Byrd-Holt D.D. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican- Americans than in non-Hispanic whites with type 2 diabetes? // Diabetes Care. - 1998. - Vol. 21. - № 8. - P. 1230-1235.
77. Kalk W.J., Joannou J., Ntsepo S., Mahomed I., Mahanlal P., Becker P.J. Ethnic differences in the clinical and laboratory associations with retinopathy in adult onset diabetes: studies in patients of African, Europen and Indian origins // J. Intern. Med. - 1997. - Vol. 241. - № 1. - P. 31-37.
78. Motala A.A., Pirie F.J., Gouws E., Amod A., Omar M.A. Microvascular complications in South African patients with long-duration diabetes mellitus // S. Afr. Med. J. - 2001. - Vol. 91. - № 11. - P. 987-992.
79. Saydah S., Eberhardt M., Rios-Burrows N., Milliams D., Geiss L., Dorsey R. Prevalence of chronic kidney disease and associated risk factors - United States, 1999 - 2004 // MMWR. - 2007. - Vol. 56. - № 8. - P. 161-165.
80. Karter A.J., Ferrara A., Liu J. Y. Ethnic disparities in diabetic complications in an insured population // JAMA. - 2002. - Vol. 287. - № 19. - P. 2519-2527.
81. Chandie Shaw P.K., Vandenbroucke J.P., Tjandra Y.I., Rosendaal F.R., Rosman J.B., Geerlings W., de Charro FT., van Es L.A. Increased endstage diabetic nephropathy in Indo-Asian immigrants living in the Netherlands // Diabetologia. - 2002. - Vol. 45. - № 7. - P. 1038.
82. The TSRD Incidence Study Group. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002 // Nephrol. Dial. Transplant. - 2006. - Vol. 21. - P. 2178-2183.
Review
For citations:
Maslova O.V., Suntsov Yu.I. Epidemiology of diabetes mellitus and microvascular complications. Diabetes mellitus. 2011;14(3):6-11. (In Russ.) https://doi.org/10.14341/2072-0351-6216
Views:
5234
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
